Latest News
Shares are trading at 50% off their highs, but that may not be enough.
Via The Motley Fool · March 7, 2026
These five stocks are all growing revenue by at least 40% annually.
Via The Motley Fool · March 7, 2026
Caterpillar is generally viewed as a construction equipment company, but it may be more than just that.
Via The Motley Fool · March 7, 2026
Via Talk Markets · March 7, 2026
Via Talk Markets · March 7, 2026
Don't fall victim to these blunders.
Via The Motley Fool · March 7, 2026
Novo Nordisk reportedly will sell its weight-loss drugs via the online pharmacy.
Via Investor's Business Daily · March 7, 2026
Microsoft stock is down more than 25% from its October highs.
Via The Motley Fool · March 7, 2026
Paramount has won the bidding war for Warner Bros. Discovery, but it was Netflix stock that soared on the news.
Via The Motley Fool · March 7, 2026
Via Talk Markets · March 7, 2026
Via Talk Markets · March 7, 2026
Has Plug Power's business reached a crucial turning point?
Via The Motley Fool · March 7, 2026
Knowing the odds could make you richer down the line.
Via The Motley Fool · March 7, 2026

This failure is not the end of the road for Netflix.
Via The Motley Fool · March 7, 2026
IonQ and D-Wave look like two of the best pure-play quantum computing companies.
Via The Motley Fool · March 7, 2026
Via Benzinga · March 7, 2026
On Saturday, Caitlin Kalinowski said she resigned from OpenAI, arguing that potential uses of AI for warrantless monitoring of Americans and weapon systems operating without a human decision demanded more careful debate than they received.
Via Benzinga · March 7, 2026
American investors are saying goodbye to American stocks.
Via The Motley Fool · March 7, 2026
On Saturday, Kevin O'Leary argued that the pandemic rewired how employers judge performance, shifting from clock-watching to a deliverables-first model where promotions and pay follow on-time execution.
Via Benzinga · March 7, 2026
Alphabet's cloud computing segment is soaring, but investors must weigh this momentum against the company's massive capital expenditure plans.
Via The Motley Fool · March 7, 2026
Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip.
Via Benzinga · March 7, 2026
Nvidia has produced tremendous returns and delivered incredible earnings, but a smaller artificial intelligence (AI) stock may produce higher gains in the future.
Via The Motley Fool · March 7, 2026
Chili's is becoming a best-in-class operator.
Via The Motley Fool · March 7, 2026